This is what analysts have to say about CVS Health Corporation (NYSE:CVS) after last week.

CVS Health Corporation (NYSE:CVS) Logo
Investors sentiment decreased to 1.25 in Q1 2019. Its down 0.64, from 1.89 in 2018Q4. It is negative, as 120 investors sold CVS Health Corporation shares while 415 reduced holdings. 126 funds opened positions while 543 raised stakes. 969.19 million shares or 6.06% less from 1.03 billion shares in 2018Q4 were reported.
Pennsylvania-based Guyasuta Investment Advsr Inc has invested 0.04% in CVS Health Corporation (NYSE:CVS). Lord Abbett And Ltd Liability Corporation reported 758,146 shares or 0.14% of all its holdings. Florida-based Aviance Capital Ptnrs Ltd Co has invested 0.23% in CVS Health Corporation (NYSE:CVS). Great Lakes Advsrs Ltd Co holds 881,727 shares or 1.06% of its portfolio. Korea Corporation owns 0.31% invested in CVS Health Corporation (NYSE:CVS) for 1.28M shares. Convergence Invest Partners Limited Co reported 25,915 shares stake. Rhumbline Advisers accumulated 0.25% or 2.40 million shares. Indexiq Advsr Ltd Limited Liability Company invested in 0.13% or 83,341 shares. New York-based Millennium Mgmt Ltd Company has invested 0% in CVS Health Corporation (NYSE:CVS). Hutchinson Capital Ca stated it has 248,797 shares or 4.04% of all its holdings. Gulf Savings Bank (Uk) Limited holds 0.29% or 306,865 shares in its portfolio. Inv House Ltd Limited Liability Company owns 27,870 shares. United Kingdom-based Aviva Public Limited Co has invested 0.22% in CVS Health Corporation (NYSE:CVS). 8,590 are held by Cutter & Co Brokerage Incorporated. Monetta Fincl Ser has invested 0.39% in CVS Health Corporation (NYSE:CVS).

Since March 1, 2019, it had 6 buys, and 0 insider sales for $1.68 million activity. LUDWIG EDWARD J had bought 2,000 shares worth $105,600. $506,016 worth of stock was bought by DORMAN DAVID W on Friday, March 8. BROWN C DAVID II bought $531,800 worth of stock or 10,000 shares.

CVS Health Corporation (NYSE:CVS) Ratings Coverage

Among 17 analysts covering CVS Health (NYSE:CVS), 15 have Buy rating, 0 Sell and 2 Hold. Therefore 88% are positive. CVS Health has $102 highest and $58 lowest target. $76.17’s average target is 31.12% above currents $58.09 stock price. CVS Health had 31 analyst reports since February 20, 2019 according to SRatingsIntel. The stock of CVS Health Corporation (NYSE:CVS) earned “Buy” rating by UBS on Thursday, February 21. Cantor Fitzgerald maintained CVS Health Corporation (NYSE:CVS) on Wednesday, February 20 with “Buy” rating. The firm has “Buy” rating given on Wednesday, February 20 by Mizuho. The firm has “Strong Buy” rating by Raymond James given on Thursday, April 18. Wells Fargo downgraded CVS Health Corporation (NYSE:CVS) rating on Wednesday, February 20. Wells Fargo has “Hold” rating and $68 target. The rating was maintained by Loop Capital Markets on Thursday, February 21 with “Hold”. The firm has “Buy” rating by Argus Research given on Monday, February 25. On Thursday, February 21 the stock rating was maintained by SunTrust with “Buy”. The stock of CVS Health Corporation (NYSE:CVS) has “Buy” rating given on Thursday, May 2 by UBS. Cowen & Co maintained the shares of CVS in report on Friday, March 15 with “Buy” rating. Below is a list of CVS Health Corporation (NYSE:CVS) latest ratings and price target changes.

01/06/2019 Broker: BidaskScore Rating: Buy Upgrade
24/05/2019 Broker: BidaskScore Rating: Hold Upgrade
18/05/2019 Broker: BidaskScore Rating: Sell Downgrade
02/05/2019 Broker: UBS Old Rating: Buy New Rating: Buy Old Target: $74.0000 New Target: $67.0000 Maintain
02/05/2019 Broker: BidaskScore Rating: Hold Upgrade
29/04/2019 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $92.0000 New Target: $74.0000 Maintain
18/04/2019 Broker: Raymond James Old Rating: Strong Buy New Rating: Strong Buy Old Target: $90 New Target: $75 Maintain
18/04/2019 Broker: Guggenheim Rating: Buy Initiates Coverage On
15/04/2019 Broker: Oppenheimer Old Rating: Outperform New Rating: Perform Downgrade
11/04/2019 Broker: BMO Capital Markets Rating: Outperform New Target: $58 Initiates Coverage On

The stock decreased 0.81% or $0.47 during the last trading session, reaching $58.09. About 3.49 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 17.14% since August 15, 2018 and is downtrending. It has underperformed by 17.14% the S&P500.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. The company has market cap of $75.54 billion. It operates through Pharmacy Services and Retail/LTC divisions. It has a 15.91 P/E ratio. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Fool.com which released: “Better Buy: Rite Aid vs. CVS Health – The Motley Fool” on July 29, 2019, also Nasdaq.com with their article: “Mid-Morning Market Update: Markets Open Lower; CVS Health Earnings Beat Views – Nasdaq” published on August 07, 2019, Investorplace.com published: “CVS Stock Bears Have Got It All Wrong – Investorplace.com” on July 25, 2019. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Finance.Yahoo.com and their article: “CVS Health Corporation Announces Expiration and Results of Any and All Tender Offers – Yahoo Finance” published on August 15, 2019 as well as 247Wallst.com‘s news article titled: “Activision, CVS, Disney, Kraft Heinz, Uber and More Earnings Coming This Week – 24/7 Wall St.” with publication date: August 04, 2019.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.